Lorianne Masuoka K. 4
4 · MARINUS PHARMACEUTICALS INC · Filed Dec 8, 2017
Insider Transaction Report
Form 4
Lorianne Masuoka K.
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2017-12-06+150,000→ 150,000 totalExercise: $6.19Exp: 2027-12-06→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Options to purchase shares of common stock vest in 36 equal monthly installments commencing 1/1/2018.